Specialization Course in Economic Evaluation of Pharmaceuticals and Medical Technologies: Basic Concepts


Classes taught in:
Start of classes:
03 March 2021
End of program:
04 May 2021
Tuition fees:

The general aim of this Course is to introduce the participant to the basic and fundamentals aspects of the main techniques and instruments used in the economic evaluation of pharmaceuticals and medical technologies throught its application to several case studies.


To justify the need to perform economic evaluations of pharmaceuticals and medical technologies in a context of scarce resources and to convey the basic knowledge of the main methods used (cost-effectiveness analysis, cost-utility analysis and cost-benefit analysis).

To develop the ability to use the necessary instruments to carry out a cost-utility type economic evaluation and the monetary valuation of the resources used (costs) in the application of a medical technology, a drug or a health program

To develop the ability to use the necessary instruments to carry out a monetary valuation of all the consequences that may result from the introduction of a new drug or medical technology by means of cost-benefit analysis techniques.

Who is it for?

This introductory course to the basic concepts of economic evaluation and pharmacoeconomics is useful for any health professional related with health economics, the pharmaceutical industry and drug management, either in public or private institutions.

Why this program?

Despite the fact that there are no previous knowledge requirements, high academic and cientific accuracy is guaranteed as the materials seen in this course are part of the Online Master in Health Economics and Pharmacoeconomics. It is directed by Prof. Jaume Puig-Junoy and Prof. Carlos Campillo-Artero and there are more than 20 editions that attest to this program's success and solidity. After successful completion of the course, there is the possibility of 6 ECTS recognition to the Master (60 ECTS).

Program curriculum

Teaching Unit 1.
Methods for the Economic Evaluation of Pharmaceuticals, Medical Technologies and Health Programs.

Teaching Unit 2.
Cost Analysis in Economic Evaluation.

Teaching Unit 3.
Cost-Utility Analysis.

Teaching Unit 4.
Cost-Benefit Analysis (1).

Practical activity (individual): analysis of how different countries develop economic evaluations of pharmaceuticals.


The program will be taught entirely online, in distance format. This involves intensive use of the virtual classroom. The teaching method used during the course will be based on case studies and participation in discussion forums.

  • Each of the 4 Teaching Units will have a specific test consisting of 10 multiple-choice questions (75% of the grade). There is a second attempt during the retake period and the system registers the highest grade.
  • Practical activity (25% of the grade): analysis of how different countries develop economic evaluations of pharmaceuticals via discussion in the forum.

Academic Director

Jaume Puig-Junoy, PhD in Economics from the UAB. Degree in Economics and Business, UAB. Lecturer UPF (1994–2019). Research in health and public sector economics, and health management. He has been director of CRES-UPF and president of AIAQS (currently AQUAS). Author of more than 200 publications